Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • Editorial Board
    • Editorial Fellowships
    • Outreach
    • Research into Publication Science
    • Advertising
    • BJGP Life
    • Feedback
    • Alerts
    • Conference
    • eLetters
    • Audio abstracts
  • RACE AND RACISM IN PRIMARY CARE
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Alerts

Search

  • Advanced search
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
Advertisement
BJGP Open

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • Editorial Board
    • Editorial Fellowships
    • Outreach
    • Research into Publication Science
    • Advertising
    • BJGP Life
    • Feedback
    • Alerts
    • Conference
    • eLetters
    • Audio abstracts
  • RACE AND RACISM IN PRIMARY CARE
Research

Valproate use in women aged 15-44 years: Observational study in general practice

Samantha Jane Beardsley, Isabel Dostal, James Cole, Ana Gutierrez and John Robson
BJGP Open 22 February 2021; BJGPO.2020.0104. DOI: https://doi.org/10.3399/BJGPO.2020.0104
Samantha Jane Beardsley
1 Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom
2 Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Dostal
2 Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Cole
2 Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Gutierrez
2 Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Robson
2 Institute of Population Health Sciences, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

Abstract

Background Valproate is a known teratogen. In April 2018, the Medicines and Healthcare products Regulatory Agency (MHRA) restricted use in women and banned use in pregnancy, except for epilepsy with no other effective treatment. To date, there is limited information on valproate prescribing within primary care.

Aim To characterise valproate prescribing to women of childbearing age, recorded advice or general practitioner prescribed contraception and recorded pregnancies.

Design & setting A cross-sectional study of patients from all 141 general practices across three Clinical Commissioning Groups in East London.

Method Women aged 15-44 years prescribed valproate between 1/10/2017-1/1/2020 were included. Exclusion criteria were early menopause, sterilisation procedures or hysterectomy. Pseudonymised data on valproate indication, pregnancy, pre-conception and contraception advice were retrospectively extracted from general practice consultation data. Data were analysed by quarter using univariate statistics.

Results Of the total 1,042,463 registered patients, 344 women aged 15–44 years were prescribed valproate during the study period; 14 were excluded. There were 10 pregnancies during possible valproate exposure; one was terminated. During the study period, the number of women prescribed valproate significantly decreased (P=0.003). The pregnancy rate decreased from 9.9/1000 on valproate before the MHRA April 2018 warning, to an average of 2.8/1000 afterwards. Recorded pre-conception/contraception advice increased by 79%, from 24% to 43%, of women prescribed valproate.

Conclusion With continued pregnancies in women aged 15-44 years prescribed valproate, patient education and foetal outcomes remain ongoing concerns. Further improvements are needed to ensure women make informed reproductive choices and safeguard future pregnancies from valproate exposure.

  • primary care
  • valproate
  • women
  • adverse drug related event
  • pregnancy
  • Received June 17, 2020.
  • Accepted August 20, 2020.
  • Copyright © 2021, The Authors

This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)

Back to top
Previous ArticleNext Article

Latest Articles

Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Valproate use in women aged 15-44 years: Observational study in general practice
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Accepted Manuscript
Valproate use in women aged 15-44 years: Observational study in general practice
Samantha Jane Beardsley, Isabel Dostal, James Cole, Ana Gutierrez, John Robson
BJGP Open 22 February 2021; BJGPO.2020.0104. DOI: 10.3399/BJGPO.2020.0104

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Accepted Manuscript
Valproate use in women aged 15-44 years: Observational study in general practice
Samantha Jane Beardsley, Isabel Dostal, James Cole, Ana Gutierrez, John Robson
BJGP Open 22 February 2021; BJGPO.2020.0104. DOI: 10.3399/BJGPO.2020.0104
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
  • Info
  • eLetters
  • PDF

Keywords

  • primary care
  • valproate
  • women
  • adverse drug related event
  • pregnancy

More in this TOC Section

  • Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study
  • Evaluation of winter pressures on general practice in Manchester: a cross-sectional analysis of nine GP practices
  • C-reactive protein cut-offs used for acute respiratory infections in Danish general practice
Show more Research

Related Articles

Cited By...

Advertisement

@BJGPOpen's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7679
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2021 BJGP Open

Online ISSN: 2398-3795